Syneron Medical (ELOS) in Focus: Stock Moves 5.9% Higher

Credit: Shutterstock photo

Syneron Medical Ltd.ELOS was a big mover last session, as the company saw its shares rise above 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.35 to $6.78 in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Syneron Medical currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

SYNERON MED LTD Price

SYNERON MED LTD Price | SYNERON MED LTD Quote

A better-ranked Medical Instruments stock is CryoLife Inc. CRY , which sports a Zacks Rank #1 (Strong Buy). can see the complete list of today's Zacks #1 Rank stocks here .

Is ELOS going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SYNERON MED LTD (ELOS): Free Stock Analysis Report

CRYOLIFE INC (CRY): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.